1. Home
  2. ICCT vs BCDA Comparison

ICCT vs BCDA Comparison

Compare ICCT & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCT
  • BCDA
  • Stock Information
  • Founded
  • ICCT 1992
  • BCDA N/A
  • Country
  • ICCT United States
  • BCDA United States
  • Employees
  • ICCT N/A
  • BCDA N/A
  • Industry
  • ICCT Computer Software: Prepackaged Software
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICCT Technology
  • BCDA Health Care
  • Exchange
  • ICCT Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • ICCT 9.1M
  • BCDA 9.4M
  • IPO Year
  • ICCT N/A
  • BCDA N/A
  • Fundamental
  • Price
  • ICCT $0.80
  • BCDA $2.95
  • Analyst Decision
  • ICCT
  • BCDA Strong Buy
  • Analyst Count
  • ICCT 0
  • BCDA 1
  • Target Price
  • ICCT N/A
  • BCDA $60.00
  • AVG Volume (30 Days)
  • ICCT 27.1K
  • BCDA 86.1K
  • Earning Date
  • ICCT 08-08-2024
  • BCDA 08-07-2024
  • Dividend Yield
  • ICCT N/A
  • BCDA N/A
  • EPS Growth
  • ICCT N/A
  • BCDA N/A
  • EPS
  • ICCT N/A
  • BCDA N/A
  • Revenue
  • ICCT $9,034,579.00
  • BCDA $468,000.00
  • Revenue This Year
  • ICCT N/A
  • BCDA N/A
  • Revenue Next Year
  • ICCT N/A
  • BCDA $436.41
  • P/E Ratio
  • ICCT N/A
  • BCDA N/A
  • Revenue Growth
  • ICCT 16.06
  • BCDA N/A
  • 52 Week Low
  • ICCT $0.78
  • BCDA $2.62
  • 52 Week High
  • ICCT $20.70
  • BCDA $35.40
  • Technical
  • Relative Strength Index (RSI)
  • ICCT 38.38
  • BCDA 37.81
  • Support Level
  • ICCT $0.81
  • BCDA $2.84
  • Resistance Level
  • ICCT $0.90
  • BCDA $3.66
  • Average True Range (ATR)
  • ICCT 0.06
  • BCDA 0.32
  • MACD
  • ICCT -0.00
  • BCDA 0.09
  • Stochastic Oscillator
  • ICCT 13.50
  • BCDA 17.44

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: